Recent Posts
News•Feb 17, 2026
Protective Mutations Associated with APOE in Alzheimer’s Disease
Recent research has identified several rare APOE mutations that confer protection against Alzheimer’s disease, including the R136S variant, the APOE3‑Christchurch (R136S) allele, loss‑of‑function CASP7, and missense changes V236E and R251G. These variants mitigate tau pathology, improve amyloid clearance, and dampen neuroinflammatory signaling, often delaying disease onset by years in high‑risk carriers. Preclinical models using AAV‑delivered APOE2‑Christchurch demonstrate robust reductions in both amyloid plaques and neurofibrillary tangles. Collectively, the findings highlight novel molecular pathways that could be leveraged for therapeutic development.
By Nature (Biotechnology)
News•Feb 16, 2026
A Large-Scale DNA Methylation Study of Alcohol Use Identified Robust Associations and Cell-Type Specific Insights
Researchers conducted the largest DNA‑methylation study of alcohol consumption to date, analyzing blood samples from 13,970 participants and deconvoluting epigenetic signals across 12 distinct blood cell types. The methylome‑wide association study identified 1,266 CpG sites reaching genome‑wide significance in whole...
By Nature (Biotechnology)
News•Feb 10, 2026
Connectome-Based Growth Models Reveal Individual Heterogeneity and Neurophysiological Subtypes of Subthreshold Depression
The study applied connectome‑based normative modeling to 197 individuals with subthreshold depression (StD), revealing that 69% exhibit extreme functional connectivity deviations. Two neurophysiological subtypes emerged: Subtype 1 with pronounced positive deviations in default‑mode, limbic and subcortical networks and negative deviations in...
By Nature (Biotechnology)
News•Feb 10, 2026
Efficacy and Safety of Pharmacological Treatments in Borderline Personality Disorder: A Systematic Review and Network Meta-Analysis
A recent systematic review and network meta‑analysis evaluated the efficacy and safety of pharmacological interventions for borderline personality disorder (BPD). The analysis pooled data from randomized trials of antipsychotics, mood stabilizers, antidepressants, and novel agents, comparing them head‑to‑head using a...
By Nature (Biotechnology)
News•Feb 10, 2026
TMS in Adolescent Depression: A Milestone FDA Clearance
The FDA granted clearance for transcranial magnetic stimulation (TMS) as an adjunctive therapy for major depressive disorder in adolescents aged 15‑21, marking the first non‑pharmacologic device approval for this group. Clinical trials show response rates as high as 96‑98% when...
By Nature (Biotechnology)
News•Feb 9, 2026
Circuit-Informed Modulation of Traumatic Memory in PTSD: Integrating Extinction, Suppression, and Reconsolidation
A new review synthesizes recent circuit‑level findings to propose an integrated model for modulating traumatic memories in PTSD. It combines extinction, memory suppression, and reconsolidation mechanisms, emphasizing the amygdala‑prefrontal‑hippocampal network and its neuromodulatory inputs. The authors highlight how this framework...
By Nature (Biotechnology)
News•Feb 9, 2026
The Many-to-Many Problem of Endophenotypes in Psychiatry - a Biological Perspective
The article argues that current psychiatric diagnostic systems and neuroimaging endophenotypes fail to capture the underlying biological complexity of mental illness. Genetic studies reveal extensive pleiotropy and overlapping risk loci across disorders, while neurotransmitter systems exhibit strong spatial colocalization, creating...
By Nature (Biotechnology)
News•Feb 9, 2026
Cerebellar Microglia-Derived IL-17A Mitigates Autism-Related Behavioral and Synaptic Deficits
Researchers discovered that cerebellar microglia are the sole source of elevated interleukin‑17A (IL‑17A) in a Fragile X mouse model of autism. The microglia‑derived IL‑17A restores Purkinje cell firing rates and normalizes synaptic inhibition, leading to improved social interaction and reduced...
By Nature (Biotechnology)
News•Feb 9, 2026
Correction: Microbiota Is Essential for Social Development in the Mouse
A correction notice was issued for the Molecular Psychiatry article that originally linked gut microbiota to social development in mice. The wrong image was published as Figure 1a and has now been replaced with the correct visual, while Figure 1b and the...
By Nature (Biotechnology)
News•Feb 7, 2026
Circulating Mitochondrial and Cellular Damage Markers in Long COVID: Links to Cognitive Function, Psychological Distress, and Inflammation
A recent Molecular Psychiatry study measured circulating mitochondrial DNA and other cellular damage markers in individuals with long COVID and found them significantly elevated compared with recovered controls. The analysis revealed strong correlations between higher mtDNA levels and reduced performance...
By Nature (Biotechnology)
News•Feb 6, 2026
Neuropsychiatric Drug Development in China: Current Status and Emerging Trends
China’s neuropsychiatric drug landscape is accelerating, driven by regulatory reforms, increased NMPA approvals, and a surge in biotech investment. In 2023 the number of CNS‑focused new drug applications grew by roughly 30%, with several first‑in‑class agents entering late‑stage trials. Emerging...
By Nature (Biotechnology)
News•Feb 6, 2026
UBE3A Isoform-Selective and Non-Selective Contributions to Angelman Syndrome Phenotypes
Researchers created a mouse model that overexpresses the cytoplasmic UBE3A isoform mIso2 and demonstrated that this manipulation fully rescues most Angelman syndrome (AS) behavioral deficits, including motor coordination, anxiety‑like behavior, and weight gain. However, the same overexpression does not correct...
By Nature (Biotechnology)
News•Feb 6, 2026
Effectiveness of Network Analysis–Driven Personalized Digital Interventions versus Standard Intervention for Depression: A Proof-of-Concept Pilot Randomized Controlled Trial
A pilot randomized controlled trial tested a network analysis‑driven personalized digital intervention against a standard digital program for adults with depression. Using person‑specific symptom networks, the experimental arm delivered tailored content, while the control received a generic module. Over eight...
By Nature (Biotechnology)
News•Feb 5, 2026
The Role of Neural Derived Extracellular Vesicles Micro-Ribonucleic Acid Cargo in White Matter Integrity in Early-Onset and Late-Onset Bipolar Disorder
Recent research isolates neural‑derived extracellular vesicles (EVs) from plasma of bipolar disorder patients and maps their micro‑RNA (miRNA) cargo, revealing distinct profiles for early‑onset versus late‑onset cases. Specific miRNAs, such as miR‑211‑5p, miR‑34a and miR‑425‑5p, correlate with diffusion tensor imaging...
By Nature (Biotechnology)
News•Feb 4, 2026
Sex Differences in the Risk of Autistic-Related Traits in Toddlers Born to Mothers with Perinatal Depression: Evidence From Human Cohort...
Maternal perinatal depression (MPD) was linked to higher autistic‑related trait (ART) scores in toddlers across a Japanese cohort of 23,218 mother‑child pairs. Women with early or mid‑gestational psychological distress or postpartum depression showed 3‑4‑fold increased odds of ART overall, while...
By Nature (Biotechnology)
News•Feb 4, 2026
Bidirectional Association Between Immune-Mediated Diseases and Major Depressive Disorder: Evidence From Cohort, Genome-Wide Pleiotropic, and Experimental Studies
A multi‑modal investigation reveals a two‑way relationship between major depressive disorder (MDD) and immune‑mediated diseases. Large cohort analyses show that depression raises the incidence of autoimmune conditions by roughly 20%, while pre‑existing autoimmune diagnoses similarly increase the risk of developing...
By Nature (Biotechnology)
News•Feb 4, 2026
Novel Selective Morpholine Trace Amine-Associated Receptor 1 Partial Agonists Show Promising Preclinical Effects for Neuropsychiatric Disorders and Are Well Tolerated...
Roche researchers have disclosed a new series of selective morpholine‑based trace amine‑associated receptor 1 (TAAR1) partial agonists that demonstrate robust antipsychotic, antidepressant and anti‑addiction activity in preclinical models. The compounds were advanced into a Phase‑1 study in healthy volunteers, where they...
By Nature (Biotechnology)
News•Feb 4, 2026
Developmental Changes of the White Matter Functional Connectome
Recent comprehensive analyses synthesize decades of neuroimaging work to map how the functional connectome of white matter evolves from childhood through late adulthood. Across longitudinal diffusion MRI and resting‑state BOLD studies, researchers observe a steady rise in inter‑regional synchrony, the...
By Nature (Biotechnology)
News•Feb 3, 2026
A Systematic Review and Meta-Analysis of the Auditory Steady-State Response in Schizophrenia, Bipolar Disorder, and Autism Spectrum Disorder
A comprehensive systematic review and meta‑analysis examined auditory steady‑state responses (ASSR), particularly the 40 Hz gamma band, across schizophrenia, bipolar disorder, and autism spectrum disorder. The analysis pooled data from over 60 studies, revealing robust reductions in ASSR amplitude and phase‑locking...
By Nature (Biotechnology)
News•Feb 3, 2026
Spatiotemporal Mapping of Brain Organisation Following the Administration of 2C-B and Psilocybin
A double‑blind, crossover fMRI study in 22 healthy volunteers compared the acute neural effects of 20 mg 2C‑B, 15 mg psilocybin, and placebo. Both psychedelics reduced within‑network static functional connectivity while broadly increasing between‑network and global connectivity, and they elevated multiple measures...
By Nature (Biotechnology)
News•Feb 1, 2026
Sleep Regulates Drug Seeking and Relapse – a Perspective
A growing body of clinical and pre‑clinical research shows that sleep disruption amplifies drug craving, impairs extinction of drug‑associated cues, and predicts relapse across substances. Mechanistic studies link these effects to orexin‑driven activation of ventral tegmental and nucleus accumbens circuits,...
By Nature (Biotechnology)
News•Jan 31, 2026
Aerobic Glycolysis in Schizophrenia: Developmental Rescue or Energetic Breakdown?
Recent research links schizophrenia to a distinct pattern of brain energy metabolism, characterized by elevated lactate, reduced glucose uptake, and mitochondrial oxidative‑phosphorylation deficits. These findings echo the Warburg‑like aerobic glycolysis observed in proliferating cells and suggest a shift toward non‑oxidative...
By Nature (Biotechnology)
News•Jan 31, 2026
Neuroinflammation: An Unfortunate Term to Describe Schizophrenia
The article argues that labeling schizophrenia as "neuroinflammation" oversimplifies a complex immune landscape. While genetics, peripheral blood markers, and epidemiology reveal systemic immune abnormalities, brain‑specific inflammatory signatures are inconsistent. Imaging studies of microglial activation and cerebrospinal fluid cytokine analyses show...
By Nature (Biotechnology)
News•Jan 31, 2026
“SHANK3 Deficiency Alters Early Progenitor Dynamics and Reveals Shared Pathways with Neurodegeneration”
A multi‑institutional study using patient‑derived iPSCs and an isogenic SHANK3‑edited line shows that SHANK3 haploinsufficiency drives transcriptional up‑regulation of cell‑cycle and DNA‑repair pathways, leading to increased progenitor proliferation and neuronal hyper‑connectivity. Bulk RNA‑seq identified 903 differentially expressed genes, with co‑expression...
By Nature (Biotechnology)
News•Jan 31, 2026
Somatostatin-Expressing Neurons in the Zona Incerta Regulate Chronic Stress Response and Modulate Depression-Like Behaviors
Researchers identified somatostatin‑expressing (SOM+) neurons in the zona incerta (ZI) as key regulators of the chronic stress response. Using optogenetic manipulation in mouse models, activation of SOM+ ZI neurons attenuated stress‑induced corticosterone elevation and reduced depression‑like behaviors, while inhibition produced...
By Nature (Biotechnology)
News•Jan 31, 2026
Splitting Schizophrenia: Divergent Cognitive and Educational Outcomes Revealed by Genomic Structural Equation Modelling
Researchers applied genomic structural equation modelling to separate schizophrenia‑specific genetic risk from the component shared with bipolar disorder. The analysis identified 63 SZ‑specific and 78 shared loci, revealing that SZ‑specific variants are linked to lower educational attainment and reduced fluid...
By Nature (Biotechnology)
News•Jan 30, 2026
Differential Protein Network and Biological Functions Atlas From Multi-Tissue Proteomics in Patients with Depression
A multi‑tissue proteomic atlas was generated from patients with major depressive disorder, revealing distinct protein interaction networks and tissue‑specific functional signatures. The study integrated label‑free mass spectrometry across brain, blood, and peripheral tissues, identifying over 5,000 quantified proteins and dozens...
By Nature (Biotechnology)
News•Jan 23, 2026
Association Between Maternal Infections During Pregnancy and Offspring Suicide Risk: A National Cohort Study
A nationwide Danish cohort study examined whether maternal infections during pregnancy raise the risk of suicide in offspring. Using linked health registers, the researchers identified over 1.2 million births and tracked maternal infection diagnoses alongside suicide outcomes up to age...
By Nature (Biotechnology)
News•Jan 19, 2026
Ferroptosis in Neurological Diseases: Moving Towards Therapeutic Intervention
Recent advances have clarified how ferroptosis—a regulated, iron‑dependent form of lipid peroxidation—contributes to a spectrum of neurological disorders, including ischemic stroke, Alzheimer’s disease, Parkinson’s disease, and multiple sclerosis. Mechanistic studies highlight the central roles of glutathione peroxidase 4 (GPX4), ferroptosis suppressor...
By Nature (Biotechnology)
News•Jan 19, 2026
Single-Cell Characterization of the Adult Male Hippocampus Suggests a Prominent, and Cell-Type Specific, Role for Nrgn and Sgk1 in Response...
Researchers generated the largest single‑cell RNA‑sequencing atlas of the adult male mouse posterior hippocampus, profiling 125,896 cells from wild‑type and conditional glucocorticoid‑receptor (GR) or mineralocorticoid‑receptor (MR) knockouts under acute social stress. The analysis identified neurogranin (Nrgn) as a robust marker...
By Nature (Biotechnology)
News•Jan 15, 2026
Associations Between Mosaic Loss and Schizophrenia or Bipolar Disorder of Young Age
Recent genomic studies reveal that somatic mosaic loss, particularly mosaic chromosomal alterations, is significantly associated with early‑onset schizophrenia and bipolar disorder. Analyses of over 12,000 schizophrenia cases identified recurrent somatic copy‑number variants disrupting NRXN1 and ABCB11, while prenatal mutational signatures...
By Nature (Biotechnology)
News•Jan 15, 2026
Psychotropic Medications and Their Interactions with Subcortical Brain Volume in Bipolar Disorder: An ENIGMA Mega-Analysis
The ENIGMA Bipolar Disorder Working Group pooled MRI data from 6,729 participants to examine how psychotropic medications influence subcortical brain volumes in bipolar disorder. Lithium use was associated with larger hippocampal and thalamic volumes, whereas antipsychotics and valproate correlated with...
By Nature (Biotechnology)
News•Jan 9, 2026
Aberrant Calcium Signaling and Neuronal Activity in the L271H CACNA1D (Cav1.3) iPSC Model of Neurodevelopmental Disease
Researchers created the first patient‑derived iPSC model carrying the de novo L271H CACNA1D (Ca_v1.3) variant linked to neurodevelopmental disease. The study shows that Ca_v1.3 is the dominant L‑type calcium channel in neural progenitor cells, where the mutation drives heightened spontaneous calcium...
By Nature (Biotechnology)
News•Jan 8, 2026
Shared Neurogenetic Architecture Links Adolescent Neurodevelopmental Deviations to Adult Psychopathological Procrastination
A new study demonstrates that the same genetic factors shaping adolescent brain development also predispose individuals to pathological procrastination in adulthood. Using twin data, high‑resolution MRI and normative modeling, researchers identified overlapping neurogenetic signatures in cortical and subcortical regions linked...
By Nature (Biotechnology)
News•Jan 8, 2026
Delay Discounting Correlates with Depression but Does Not Predict Relapse After Antidepressant Discontinuation
The AIDA longitudinal study examined whether delay discounting could predict depressive relapse after antidepressant discontinuation. While patients with remitted major depressive disorder displayed modestly higher discount rates than healthy controls and discounting correlated with HAM‑D scores, baseline discounting and changes...
By Nature (Biotechnology)
News•Jan 7, 2026
Correction: GRIN2A Null Variants Confer a High Risk for Early-Onset Schizophrenia and Other Mental Disorders and Potentially Enable Precision Therapy
Researchers led by Lemke et al. report that loss‑of‑function (null) variants in the GRIN2A gene markedly increase the risk of early‑onset schizophrenia and related psychotic disorders. By integrating genome‑wide data from more than 10,000 individuals with detailed functional assays, the study...
By Nature (Biotechnology)
News•Jan 7, 2026
Comparative Efficacy and Safety of Different Surgical Strategies for Refractory Obsessive-Compulsive Disorder: Evidence From Network Meta-Analysis
A recent network meta‑analysis evaluated the comparative efficacy and safety of surgical interventions for treatment‑refractory obsessive‑compulsive disorder (OCD), focusing on ablative procedures such as gamma ventral capsulotomy and lesion‑based capsulotomy versus deep brain stimulation (DBS) targeting regions like the ventral...
By Nature (Biotechnology)
News•Jan 6, 2026
Synaptic Potentiation Requires PARP1 Activation: Prevailing Concepts Are Revisited
A recent Mol Psychiatry study reveals that poly‑ADP‑ribose polymerase 1 (PARP1) activation is indispensable for long‑term synaptic potentiation (LTP) and memory formation. The authors demonstrate a DNA‑independent activation pathway where phosphorylated Erk2 binds PARP1, exposing its NAD⁺ site and triggering poly‑ADP‑ribosylation...
By Nature (Biotechnology)
News•Jan 5, 2026
RO4938581, a GABAA-Α5 Negative Allosteric Modulator Rescued Behavioral and EEG Phenotypes of a Mouse Model of Dup15q Syndrome
The study shows that mice carrying the 15q duplication exhibit ~1.5‑fold elevation of GABA A‑α5 receptors in cortex, hippocampus and striatum, leading to heightened inhibitory synaptic activity and a characteristic increase in beta‑band EEG power. Chronic oral administration of the selective...
By Nature (Biotechnology)
News•Jan 3, 2026
Epigenetic Mechanisms Affected by Stress During Adolescence and the Increased Risk for Depression Later in Life: A Systematic Review
This systematic review examined how stressful life events during adolescence reshape epigenetic landscapes and elevate depression risk later in life. By screening 30 preclinical and clinical studies, the authors identified consistent DNA methylation and micro‑RNA changes—particularly affecting the BDNF pathway—in...
By Nature (Biotechnology)
News•Dec 29, 2025
Structural Covariance, Regional Topology, and Volumetric Aspects of Amygdala Subnuclei in Posttraumatic Stress Disorder Using Ultra-High Field Imaging
Using ultra‑high‑field 7 T MRI, researchers examined amygdala subnuclei volumes, network topology, and structural covariance in 73 PTSD patients, 78 trauma‑exposed controls, and 59 non‑trauma controls. Whole‑amygdala size was unchanged, but the lateral nucleus showed opposite volume shifts: larger left lateral...
By Nature (Biotechnology)